Conmed (CNMD) Misses Q4 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/28/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
Tweet
Share
E-mailGet Alerts CNMD Hot Sheet
Price: $47.20 --0%
EPS Growth %: -7.4%
Financial Fact:
Net Income Diluted: 0.26
Today's EPS Names:
GBFH, JMKE, FDX, More
EPS Growth %: -7.4%
Financial Fact:
Net Income Diluted: 0.26
Today's EPS Names:
GBFH, JMKE, FDX, More
Join SI Premium – FREE
Conmed (NASDAQ: CNMD) reported Q4 EPS of $0.54, $0.02 worse than the analyst estimate of $0.56. Revenue for the quarter came in at $204.1 million versus the consensus estimate of $204.04 million.
Expects FY 2017 sales to grow 1-3% on constant currency basis
For earnings history and earnings-related data on Conmed (CNMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- OppFi Inc. (OPFI) Tops Q3 EPS by 2c ; Offers Guidance
- The Ensign Group (ENSG) Tops Q3 EPS by 6c; raises guidance
- Deutsche Bank Aktiengesellschaft (DB) Tops Q3 EPS by 2c; offers outlook
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
